Fungal infection in her knee [joint infection] ([cryptococcus antigen positive]) has been on crutches [walking aid user].Case narrative: initial information received on 11-sep-2018 regarding an unsolicited valid serious case received from a patient from united states.This case involves a (b)(6) years old female patient who received treatment with hylan g-f 20, sodium hyaluronate (synvisc one) and after unknown latency had experienced fungal infection in her knee and has been on crutches.The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.On an unknown date in (b)(6) 2017, the patient received intra-articular hylan g-f 20, sodium hyaluronate injection, 1 df, once, (lot - 6rsl047, 31-oct-2019) in left knee for knee osteoarthritis.On an unknown date, since the injection, patient was on crutches.On an unknown date, patient ended up going to the emergency room (er) and she was diagnosed with a fungal infection in her knee which was a cryptococcus infection.Patient was requesting compensation for this.Final diagnosis was has been on crutches and fungal infection in her knee.Corrective treatment was not reported for fungal infection in knee and crutches for walking aid user.The patient outcome is reported as not recovered for both events a pharmaceutical technical complaint (ptc) was initiated on 17-sep-2018 for synvisc one with global ptc number: (b)(4).The production and quality control documentation for lot 6rsl047 expiration date (2019-10-31) was reviewed.The investigation showed that the product met specifications.No associated non-conformances were noted.Based on the lot batch record review & lot frequency analysis for lot 6rsl047 no capa was required.Sanofi global pharmacovigilance and epidemiology continuously monitored adverse event reports with or without lot numbers and assessed possible associations with their corresponding product lot, as part of routine safety surveillance effort to detect safety signals.This review has not indicated any safety issue.As of 17-sep-2018 there were 6 complaints on file for lot # 6rsl047: (4) tip breakages, (1) missing luer-lok hub and (1) adverse event report.Sanofi will continue to monitor complaints to determine if a capa is required.Seriousness criteria: medically significant for fungal infection in knee and disability for has been on crutches additional information was received on 17-sep-2018.Global ptc number and results were added.Text was amended accordingly.
|